Posted on

ChromaWay and the Inter-American Development Bank Collaborate to Improve Property Registration using the Chromia Blockchain

According to a recent report published by the IADB, the LAC PropertyChain pilot shows that “complex property transactions can be sufficiently modeled, coded, and processed on a distributed blockchain network.”. The report goes on to explain how the technology can alleviate problems that currently plague real estate transactions in Latin America. STOCKHOLM, SWEDEN, February 01, 2023 – (SEAPRWire) – The Inter-American Development Bank (IADB) and ChromaWay, a provider of enterprise-grade blockchain solutions, have collaborated on a pilot program that demonstrates the ability of Chromia blockchain technology to improve property registration processes in Latin America. The program, called LAC PropertyChain, ran on a permissioned version of Chromia and aimed to increase the transparency of records, streamline the property registration process, generate greater trust among stakeholders, and reduce accessibility barriers. The prototype was based on Peruvian law and focused on two processes particularly relevant to local stakeholders: mortgage discharge and property subdivision. The development team modeled the workflow and tasks associated with these transactions and developed a hybrid smart contract to programmatically enforce the process among ecosystem partners such as buyers, sellers, attorneys, surveyors, banks, notaries, and land registration authorities. Commenting on the recent project collaboration, ChromaWay’s VP of Business and Partnership Development Todd Miller said: “Not only did the pilot demonstrate that blockchains can play a central role in property registration infrastructure, it also demonstrated that Chromia’s features make it better suited to the task than other smart contract platforms.” Chromia performed well due to its ability to handle large datasets using relational blockchain technology. Unlike other smart contract platforms, Chromia has native relational database support, allowing for efficient storage, search, and editing of records. Additionally, the ability of Chromia to interoperate seamlessly with external enterprise business applications allowed participants to interact with LAC PropertyChain without prior knowledge of blockchain technology. The pilot project is currently being reviewed by the IADB for the next steps. It is also being used as a model for other projects under consideration in Latin America, Africa, and Asia. If users are interested in learning more, please contact ChromaWay or visit the LAC PropertyChain website. Users may also view the full Inter-American Development Bank report in Spanish and in English. About ChromaWay ChromaWay, established in 2014, is the creator of the relational blockchain Chromia – a new architecture that combines the power and flexibility of a relational database with the decentralized security of a blockchain. ChromaWay has developed applications for clients across the globe in several sectors, including banking, supply chain, real estate, and green finance. About Chromia Chromia combines databases with blockchain to deliver a general purpose “relational blockchain” platform capable of supporting nearly every kind of decentralized application. Relational database support makes Chromia particularly well suited to applications requiring high I/O capacity and the management of complex data sets while offering the security and transparency of a public blockchain. Media Contact Company: ChromaWay Contact: Fati Hakim Email: fati.hakim@chromaway.com Website: https://chromaway.com/ SOURCE: ChromaWay The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)

Read More
Posted on

Pri 1 registration: Phase for kids of alumni and school advisory board members to open on July 7

SINGAPORE - The next phase of Singapore's Primary 1 registration exercise will open at 9am and end at 4.30pm on Wednesday (July 7). Phase 2A(1) is reserved for children whose parents are alumni or members of the school's advisory board. There is likely to be some balloting at this stage - which happens when a school receives more applications than there are available places. Last year, four popular schools held ballots for this phase - CHIJ St Nicholas Girls', Nan Hua Primary, Rosyth and Pei Hwa Presbyterian. The Ministry of Education (MOE) will release the results by SMS on July 13. Like last year, the registration exercise this year is fully online due to the Covid-19 situation. For phase 2A(1), parents can find the registration form at the MOE website. This is the second phase of this year's exercise. Phase one - which is reserved for children who have older siblings already enrolled in the school - was held from June 30 to last Thursday. It saw seven primary schools fill more than half their available Primary 1 places. Of the 181 primary schools, 50 have filled at least 40 per cent of their vacancies. The primary school with the most applications in that phase was Horizon Primary in Punggol, with 138 of its 240 Primary 1 slots - 57.5 per cent - filled. However, vacancies have not filled up as quickly as last year - when 70 schools had at least 40 per cent of their slots filled after phase one. There are seven phases in total and the exercise will run until October. More on this topic   Related Story P1 registration: Are you likely to face balloting at the school of your choice?   Related Story Primary 1 registration guide: What parents need to know for online exercise

Read More
Posted on

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration

HONG KONG, May 24, 2021 - (ACN Newswire via SEAPRWire.com) - Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products of the Company, namely Bimatoprost Timolol eye drop (a potential first-to-market generic drug in China targeting glaucoma, a fixed dose combination of a prostaglandin analogue and a beta-blocker) and Epinastine HCl eye drop (a potential first-to-market generic drug in China targeting allergic conjunctivitis with a dual mechanism of action of anti-histamine and mast cell stabilization), passed the on-site inspection for drug registration of the Greater Bay Area Center for Drug Evaluation of NMPA. The inspection verified the original records and information on the research and development as well as the manufacturing processes of the above two drug products.The Company also passed the Good Manufacturing Practice (GMP) compliance inspection conducted by the Guangdong Medical Products Administration. It confirms that the Company has put in place a GMP management framework, a core team, a complete set of analytical instruments, equipment and facilities, a well-managed documentation system and proper operations of the production and quality systems.Passing the on-site inspection for drug registration and GMP compliance is a major milestone for the Company. The positive result of the on-site inspection for drug registration of the Company as the first by any enterprise to complete such inspection conducted by the Greater Bay Area Center for Drug Evaluation of NMPA signifies NMPA's approval of the capacity of the Company's drug research and development system as well as the quality management system. It also validates that such systems can produce products compliant with the registration requirements in a sustained and consistent fashion.The Company's manufacturing facility occupies approximately 7,600 sq.m. in Nansha New District, Guangzhou. It is designed and built for ophthalmic drugs in compliance with cGMP requirements of China, the United States and the EU with full manufacturing capability and ready for commercial-scale production. The Company is currently expanding its manufacturing capacity and expects to complete the expansion by the end of 2022.Dr. Li Xiaoyi, Chairman of the Board, Executive Director and CEO of Zhaoke Ophthalmology, said, "The eye is a very sensitive organ of the human body, so we attach great importance to our production quality and safety, and strive to provide patients with the safest and highest quality products. Quality manufacturing is one of the core pillars of Zhaoke, passing the on-site inspection by the NMPA is a strong accreditation for the Company. It affirms all the hard work that we have put in over the years to ensure a quality manufacturing system."The Company has submitted the abbreviated new drug application (ANDA) for both of the aforementioned generic drugs (Bimatoprost Timolol eye drop and Epinastine HCl eye drop) to NMPA. The Company expects to commence commercialization of these two products upon receiving their regulatory approvals in 2022. Their commercialization is expected to address the unmet needs by glaucoma patients and help the Company forge a close bond with downstream strategic channels such as partners, key opinion leaders, ophthalmologists and hospitals.About Zhaoke Ophthalmology LimitedZhaoke Ophthalmology Limited is an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs in China. The Company has built a comprehensive ophthalmic drug pipeline of 25 candidates, comprising 13 innovative drugs and 12 generic drugs, that covers most major ocular indications affecting the front and the back of the eye, through either in-house development or in-licensing. The Company has developed internal capabilities in key aspects of ophthalmic drug development. The Company's specialized in-house research, development, clinical and regulatory capabilities have enabled it to concurrently advance multiple innovative and generic drug candidates through the preclinical and clinical stages. The Company has established a commercial-scale advanced manufacturing facility, which is designed and built for ophthalmic drugs in compliance with cGMP requirements of China, the United States and the European Union. The Company is led by an international management team with decades of industry experience and a track record of research and development, clinical operations, manufacturing, regulatory communications, business development and commercialization of ophthalmic therapies.Zhaoke Ophthalmology has received strong endorsement from blue-chip pre-IPO investors, including GIC, Hillhouse Capital, TPG, Loyal Valley Capital, Orbimed and Aier Eye Hospital. The Company recently completed its HK IPO with cornerstone investors including CaaS Capital, GIC, Golden Valley, Jennison, Mass Ave, Matthews Asia, OrbiMed and VMS Investment. Issued by Porda Havas International Finance Communications Group for and on behalf of Zhaoke Ophthalmology Limited. For further information, please contact:Porda Havas International Finance Communications GroupZhaoke.hk@pordahavas.com Copyright 2021 ACN Newswire. All rights reserved. (via SEAPRWire)

Read More
Posted on

Primary 1 registration for 2022 will open on June 30, be online for second year in view of Covid-19

SINGAPORE - Primary 1 registration for next year will open on June 30, the Ministry of Education (MOE) said on Thursday (May 20). This year's exercise will not be affected by the ongoing review of the Primary 1 registration framework, which was raised in Parliament during the Budget debate in March. The ministry is reviewing the framework to see how it can increase the number of places set aside under Phase 2C - the open phase for those who do not enjoy any form of priority admission, and is based on home-to-school distance. For the second year in a row, registration will be online in view of the Covid-19 pandemic. Parents can register through two modes of registration depending on which phase their child is in. For parents registering their child under Phase 1 - which allows parents to register their younger child at the school where an older child is currently studying - the school will provide parents with more details on how to register their younger child during the registration period using an online application form. For Phases 2A(1), 2A(2) and 2B, the link to the online application form and user guide will be available on the MOE Primary 1 registration website, as well as the periods when the registration opens for these phases. Phase 2A(1) is for parents who are alumni or who are members of the advisory or management committee of the school. This phase takes place on July 7 from 9am to 4.30pm and its results will be out on July 13. Phase 2A (2) applies to children whose siblings previously studied in the school of their choice or are studying in an MOE kindergarten located in that school. Parents who are staff of the school or are alumni can also apply under this phase. It will run from 9am on July 14 to 4.30pm on July 15. Successful applicants will be notified on July 23. Parent volunteers who joined no later than July 1 last year with at least 40 hours of service by June 30 or those registered with clan or church groups connected, among others, can register during Phase 2B. This phase takes place from 9am on July 26 to 4.30pm on July 27. The result will be released on Aug 2. For Phases 2C and 2C Supplementary, parents who did not or could not apply in the earlier phases will have to register on the Primary 1 Internet System (P1-IS) and they can refer to this website (https://www.moe.gov.sg/primary/p1-registration/how-to-register?pt=2C) for more information to register. The two phases begin in August. MOE reiterated that parents should choose a school suitable to their child's learning needs and interest. Under the Compulsory Education Act, Singapore citizens born after Jan 1, 1996, and residing in the country are required to attend national primary schools, including government-funded Special Education (Sped) schools. Those born between Jan 2, 2015, and Jan 1, 2016, must either participate in this year's Primary 1 registration exercise for admission next January or enrol in the Junior 1/Primary 1 programme of a Sped school. International pupils will continue to register under Phase 3 after all Singaporeans and permanent residents have been allocated a place under the earlier phases. Those who wish to do so must undergo a two-step process that involves submitting an online form on the MOE Primary 1 website from June 1 to June 7. They will not be able to register during Phase 3 if they do not do so by June 7. MOE will notify international pupil applicants in October whether they have been offered a place via e-mail. Meanwhile, infrastructure upgrading plans for two primary schools have been put on hold or delayed. Bukit View Primary School will continue operating at its current location at 18 Bukit Batok Street 21. It was scheduled to move to a holding site from January while its permanent campus undergoes upgrading. As MOE is further reviewing the project, the upgrading plan has been put on hold and the school will not move yet. St. Margaret's Primary School will also continue to operate from its current holding site in Mattar Road. As there is a delay in the upgrading project of its permanent site, the school will continue to operate from where it is currently located for another year until December 2023, said MOE. As both the online application form and Primary 1-IS registration requires Singpass, parents are advised to set up their Singpass 2-Step Verification early and ensure that their Singpass account is valid before the commencement of the Primary 1 registration exercise. Those who need further help may contact their school of choice using e-mail or telephone on the respective registration days between 9am and 4.30pm. Links to the online forms, user guides, declaration process and eligibility criteria can be found at https://www.moe.gov.sg/primary/p1-registration From Thursday, parents of prospective Primary 1 pupils will also be able to download and register for MOE's Parents Gateway app on their mobile devices using their Singpass account. The app notifies parents about updates and information on the Primary 1 registration exercise process and requirements. It will also inform them about administrative tasks before the start of school such as Primary 1 orientation dates, purchase of school uniforms and book supplies.

Read More